Medicine

Pfizer launches COVID-19 vaccine trial in pregnant women

Pfizer and BioNTech will jab approximately 4000 pregnant women with their experimental COVID-19 vaccines in an effort to understand the vaccine's effects. Globally, millions have already received shots of the vaccines authorized for emergency use.

By Anastasia Andric

February 22, 2021
at 5:37 PM

Approximately 4000 pregnant women will participate in a vaccine trial involving the administration of Pfizer and BioNTech’s COVID-19 vaccines.

The women will receive a jab of one of the vaccines to help researchers understand how the vaccine impacts the underresearched group. Millions across the world have already received shots of the experimental vaccines which are still undergoing trials and peer-reviews.

It is recommended by the Centers for Disease Control and Prevention that pregnant women speak to a health care provider about the vaccine and its relative risks before taking it.

ORIGINAL SOURCE

Anastasia Andric

Anastasia is a curious and enthusiastic storyteller, with a degree in Journalism from Ryerson University. She has a love for the news and is passionate about reporting on issues that matter. She is dedicated to informing the public with accurate, timely, and relevant news. She is not afraid to dig deep and ask the tough questions to get to the real story.